Eli Lilly & Co has recalled approximately 9,380 vials of Erbitux (cetuximab) Injection, a prescription medication. The recall was initiated because some vials may be missing their primary container labels, which means critical information about the medication, dosage, and expiration date would not be visible on the vial itself. This issue affects Erbitux 200 mg/100 mL single-use vials that were distributed to healthcare providers in several states and Puerto Rico.
A missing label on a medication vial poses a risk of medication errors, as healthcare providers might be unable to verify the drug name, concentration, or expiration date before administration. Using an unidentified or incorrect medication could lead to serious adverse health consequences or ineffective treatment.
Pharmacy refund and healthcare consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.